Ultragenyx
Biotechnology
Healthcare
RARE
96.29 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
29.39
52 week high
59.36
high
29.64
52 week low
0.00
low
28.28
growth
-51.66 %
previous Close
29.47
P/E ratio
market cap
3.43 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
108.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top